Patents by Inventor Achyut Adhikari

Achyut Adhikari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10501472
    Abstract: The invention relates to a novel method to isolate a natural product, a flavonoid namely inoscavin A from a Sri Lankan mushroom, medicinal preparation thereof to treat rhabdomyosarcoma cancer condition. This compound was isolated from the terrestrial basidiomycete Fulviformes fastuosus for the first time. The isolation method of the inoscavin A comprises the following steps of: (1) carrying out sonication extraction of pulverized specimen by methanol; (2) partitioning in to hexane, dichloromethane and ethyl acetate respectively by liquid-liquid extraction 3) fractionation using normal phase silica gel column chromatography 4) purification using preparative high performance liquid chromatography (HPLC) to obtain flavonoid compound inoscavin A in substantially purified form (?98%). In vitro cytotoxicity experiments demonstrated that the composition comprising inoscavin A strongly induced the apoptosis of human rhabdomyosarcoma (RD) cells compared to the cytotoxicity produced on normal epithelial cells (CC-1).
    Type: Grant
    Filed: November 23, 2015
    Date of Patent: December 10, 2019
    Inventors: Dilusha Fernando, Ravi Wijesundera, Preethi Soysa, Dilip de Silva, Chandrika Nanayakkara, Achyut Adhikari
  • Publication number: 20180370985
    Abstract: The invention relates to a novel method to isolate a natural product, a flavonoid namely inoscavin A from a Sri Lankan mushroom, medicinal preparation thereof to treat rhabdomyosarcoma cancer condition. This compound was isolated from the terrestrial basidiomycete Fulviformes fastuosus for the first time. The isolation method of the inoscavin A comprises the following steps of: (1) carrying out sonication extraction of pulverized specimen by methanol; (2) partitioning in to hexane, dichloromethane and ethyl acetate respectively by liquid-liquid extraction 3) fractionation using normal phase silica gel column chromatography 4) purification using preparative high performance liquid chromatography (HPLC) to obtain flavonoid compound inoscavin A in substantially purified form (?98%). In vitro cytotoxicity experiments demonstrated that the composition comprising inoscavin A strongly induced the apoptosis of human rhabdomyosarcoma (RD) cells compared to the cytotoxicity produced on normal epithelial cells (CC-1).
    Type: Application
    Filed: November 23, 2015
    Publication date: December 27, 2018
    Applicants: University of Colombo, National Research Council
    Inventors: Dilusha Fernando, Ravi Wijesundera, Preethi Soysa, Dilip de Silva, Chandrika Nanayakkara, Achyut Adhikari
  • Patent number: 10005809
    Abstract: The present invention relates to 5-O-[6?-(3-hydroxy-3-methyl glutarate)?-D-glucoside as a new antioxidant.
    Type: Grant
    Filed: February 5, 2013
    Date of Patent: June 26, 2018
    Inventors: M. Iqbal Choudhary, Juveria Siddiqui, Ahmed Abbaskhan, Suad Naheed, Achyut Adhikari, Jalauddine A. Jalal Awalia
  • Publication number: 20140221634
    Abstract: The present invention relates to 5-O-[6?-(3-hydroxy-3methyl glutarate)?-D-glucodise as a new antioxidant.
    Type: Application
    Filed: February 5, 2013
    Publication date: August 7, 2014
    Inventors: M. Iqbal Choudhary, Juveria Siddiqui, Ahmed Abbaskhan, Suad Naheed, Achyut Adhikari, Jalauddine A. Jalal Awalia